Literature DB >> 10830427

Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.

H H Fernandez1, M C Lannon, J H Friedman, B P Abbott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10830427     DOI： 10.1002/1531-8257(200005)15:3<579::AID-MDS1024>3.0.CO;2-0

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  10 in total

Review 1.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

Review 2.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Daniel Weintraub; Howard I Hurtig
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

Review 3.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

4.  The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview.

Authors:  T Prohorov; C Klein; A Miniovitz; E Dobronevsky; J M Rabey
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

5.  Psychosis Due to Neurologic Conditions.

Authors:  David B. Arciniegas; Jeannie L. Topkoff; Kerri Held; Lauren Frey
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

Review 6.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 7.  Treatment of psychosis in Parkinson's disease: safety considerations.

Authors:  Hubert H Fernandez; Martha E Trieschmann; Joseph H Friedman
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

9.  Dementia in parkinsonism.

Authors: 
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

Review 10.  Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action.

Authors:  Tay Kay Yaw; Susan H Fox; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2015-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.